Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| Upstream (Parents) |
|---|
| (<<) IL2RG → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| (<<) UBE2L6 → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| (<<) HLA-C → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| (<<) HLA-G → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| Downstream (Children) |
|---|
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → C2orf76 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → WT1 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → ZNF704 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → TACC2 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → C10orf47 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → RPS20 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → KHDC1///SPA17 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → RPL27A (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → C10orf10 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → ZNF827 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → SLC39A10 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → HLA-C (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → LOC286052 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → HLA-G (>>) |
